Tiptree will “revisit” whether to float Fortegra “at some point”
Tiptree’s chairman has said the New York-based holding company will revisit the question of whether to float Fortegra, after the insurance subsidiary posted a 79.2 percent increase in gross written premiums and premium equivalents in Q2.
Want to read this article?
Subscribe for FULL access to this article - and ALL our premium content
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Spencer Halladey
Commercial director
Email: spencer.halladey@wbmediagroup.com
Tel: +44 (0) 203 934 6687
Andy Stone
Sales manager
Email: andy.stone@wbmediagroup.com
Tel: +44 (0) 203 934 6684
Subscribers get access to:
- Full web access to all content
- Regular breaking news/analysis by email on all critical issues
- Two daily round-ups of the day’s news
- Opinion from market thought-leaders and exclusive data on the industry
- Control over the content you receive - and WHEN you receive it
- Access to The Insurer App
- Discounted subscriber prices for all our events
- Dedicated account manager to ensure you receive the best value for money